Skip to Main Content

Paper Details

A potent and broad neutralization of SARS-CoV-2 variants of concern by DARPins.
Nat Chem Biol
8
2023
ACE2, B, DARPin, DARPins, FSR16m, FSR22, K18, SARS, SARS-, SARS-CoV, SARS-CoV-2, SR16m, SR22, T4 foldon, angiotensin-converting enzyme 2, hACE2, mice, severe acute respiratory syndrome coronavirus, spike protein
Author NameAffiliation
Young Do KwonVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Lawrence ShapiroColumbia University
Lawrence ShapiroColumbia University
Yaroslav TsybovskyVaccine Research Center Electron Microscopy Unit, Frederick National Laboratory for Cancer Research
Ningyan ZhangTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston
Michael S DiamondWashington University School of Medicine
Michael S Diamondand The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
Peter D KwongVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Zhiqiang AnTexas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston
  • 1 - 9

Datasets